GPLD1通过双膜定位减轻心力衰竭,以抑制uPAR
Wenjing Yu1,2, Zhen Guo1,2, Huimin Liang1
1National and Local United Engineering Laboratory of Druggability and New Drugs Evaluation, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Guangdong Province Engineering Laboratory for Druggability and New Drug Evaluation, School of Pharmaceutical Sciences (W.Y., Z.G., H.L., D.M., C.L., Z. Li, J.Y., P.L., J.L.), Sun Yat-sen University, Guangzhou, China.
Circulation research
|July 9, 2025
概括
葡萄糖酸氨基醇特异性脂酶D1 (GPLD1) 通过维持细胞平衡和线粒体功能来防止心力衰竭 (HF). 泌尿酸酶类型的等离子体激活剂受体 (uPAR) 相互作用是GPLD1在心脏功能障碍中的保护作用的关键.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 生物化学 生物化学
背景情况:
- 甘酸酸氨基醇特异性脂酶D1 (GPLD1) 在与年龄相关的损伤中的作用已知,但其在心血管疾病,特别是心力衰竭 (HF) 中的功能尚不清楚.
- 调查GPLD1在HF中的参与对于确定新的治疗点至关重要.
研究的目的:
- 阐明GPLD1在心力衰竭的发病过程中的作用和机制.
- 为了确定GPLD1是否可以作为心脏功能障碍的治疗点.
主要方法:
- 在人类HF患者和小鼠HF模型中分析GPLD1和UPAR (urokinase类型等离子体激活受体) 水平.
- 在心脏特异性HF小鼠模型中对GPLD1和UPAR进行基因操纵.
- 蛋白质组分析以确定GPLD1结合伙伴和涉及细胞信号通路,膜局部化和线粒体功能的机制研究.
主要成果:
- 在HF患者和模型中,GPLD1水平升高. 心脏特异性GPLD1枯竭使HF恶化,而过度表达改善了心脏功能.
- GPLD1与UPAR相互作用,这种相互作用对其保护作用至关重要. GPLD1定位在血和线粒体膜上,以切割UPAR的,保持和线粒体平衡.
- uPAR过度表达破坏了GPLD1的定位和功能,加剧了心脏功能障碍.
结论:
- GPLD1作为一种内源性防护因子,防止心力衰竭.
- 准GPLD1代表了治疗心脏功能障碍和高血压的潜在治疗策略.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
516
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
516
01:29Heart Failure II: Pathophysiology
51
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
51
01:17Pathophysiology of Heart Failure
1.9K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
01:12GPCR Desensitization
6.5K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.5K
01:22Heart Failure Drugs: Diuretics
500
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
500
01:30Cardiomyopathy II: Dilated Cardiomyopathy
30
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
30